|
 |
CymbaltaThis page contains recent news articles, when available, and an overview of Cymbalta but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Cymbalta (when available) Duloxetine is in a class of medications called selective serotonin and norepinephrine reuptake inhibitors (SSNRIs) and primarily targets major depressive disorders (MDD) and stress urinary incontinence (SUI). Duloxetine is also used to treat pain and tingling caused by diabetic neuropathy (damage to nerves that can develop in people who have diabetes). Known also as LY248686, it is a potent dual inhibitor of serotonin (5-hydroxytryptamine, 5-HT) and norepinephrine (NE) reuptake, possessing comparable affinities in binding to NE and 5-HT transport sites. Interestingly, its behavior contrasts to most other dual-reuptake inhibitors. Furthermore, duloxentine lacks affinity for monoamine receptors within the central nervous system. For the treatment of major depressive disorder (MDD). Mechanism Of Action: Duloxetine is a potent inhibitor of neuronal serotonin and norepinephrine reuptake and a less potent inhibitor of dopamine reuptake. Duloxetine has no significant affinity for dopaminergic, adrenergic, cholinergic, histaminergic, opioid, glutamate, and GABA receptors. The antidepressant and pain inhibitory actions of duloxetine are believed to be related to its potentiation of serotonergic and noradrenergic activity in the CNS. News Articles on Duloxetine Lilly Posts Third-Quarter Profit, Boosts Forecast - Oct 21, 2009 Revenue from Zyprexa, the antidepressant Cymbalta, the cancer drug Alimta and impotence pill Cialis all increased. Lilly also reiterated plans to reduce ... Bloomberg Lilly CEO optimistic despite patent cliff - Nov 9, 2009 He cited expectations of growing sales from cancer drug Alimta, antidepressant Cymbalta, anti-impotence treatment Cialis and recently approved blood-clot ... Reuters Marcial: Is Eli Lilly Ripe for a Rebound? - Nov 10, 2009 Lilly could lose an estimated 36% of its 2008 revenues of $20.3 billion from patents expiring on Zyprexa and Cymbalta by 2013. And, as some bears assert, ... BusinessWeek Lilly Hires Astra Research Chief - Nov 13, 2009 He shepherded the development of several drugs, including antidepressant blockbuster Cymbalta and anti-clotting medicine Effient launched in July, ... Wall Street Journal Majority of Surveyed Physicians Prescribe Cymbalta and Lyrica for Treatment of ... - Oct 21, 2009 In the case of Cymbalta, surveyed rheumatologists report that 37 percent of their prescriptions for the drug are in the first line; in the case of Lyrica, ... Reuters Sought-After Speaker, With Script Outlines From Eli Lilly - Nov 3, 2009 ...care professionals about disorders like schizophrenia and depression, which can be treated with the Lilly drugs Zyprexa and Cymbalta respectively. ... New York Times Marketing Drugs: The Pitfalls of DTC - Nov 5, 2009 The study sites the difference between the DTC campaign for Boniva and Cymbalta. While Cymbalta spent the most money, according to the study, ... BusinessWeek Generic Name: Duloxetine, Yentreve - Nov 11, 2009 Cymbalta (generic name: Duloxetine; brand name: Yentreve) is a type of antidepressant known as a serotonin and noradrenaline reuptake inhibitor (SNRI). ... Pattaya Daily News Study: Drug ads drive side-effect worries - Nov 10, 2009 ...(NYSE:LLY) of Indianapolis spent the biggest amount on an ad campaign last year, $179 million on ads touting the antidepressant Cymbalta. ... The Daily Deal Lilly's promo deal with CVS draws fire - Oct 19, 2009 Eli Lilly is catching heat for paying CVS Caremark to promote its Cymbalta drug to doctors. The CVS pharmacy benefits manager has been sending promotional ... FiercePharma Is It Bipolar Disorder or Depression? Learn the Signs - Nov 4, 2009 Other treatments for major depression include Cymbalta and Effexor, which are SNRIs or serotonin norepinephrine reuptake inhibitors. ... FOXNews Drug Makers to Press for Guidance on Web Marketing - Nov 11, 2009 The company says it is trying to figure out how to advertise medicines for which the FDA requires prominent safety warnings, such as Cymbalta, which is used ... Wall Street Journal Research and Markets: Commercial Insight: Antidepressants - Novel Mechanism ... - Oct 27, 2009 Eli Lilly's efforts to gain a broad range of indication approvals for Cymbalta has been a key differentiator from Effexor (venlafaxine, Wyeth). ... Reuters Verilogue Study: Does Higher DTC Spend Result in Positive Patient-Physician ... - Nov 9, 2009 ...while the other half expressed negative sentiments (eg “No, I don't want to take Cymbalta. And I don't like the commercials, and plus I'm on Zoloft and ... Business Wire (press release) Woman facing charges after traffic accident - Nov 3, 2009 An officer said Davis gave police permission to search her purse and inside they found Abilify, Cymbalta, Estradiol and Detrol. She failed a field sobriety ... Port Clinton News Herald Best Branded TV Campaign - Oct 29, 2009 Draftfcb and Eli Lilly's long-running “Depression Hurtsâ€? campaign for Cymbalta has been incredibly successful and effective, and it continues to win ... Medical Marketing and Media Hostage drama ends with no shots fired - Nov 10, 2009 Craft said where he needed to be was a psychiatric ward, mentioning he had previously been on Cymbalta for depression. He was told by the judge that there ... Catskill Daily Mail About this author: - Oct 20, 2009 Investors will look forward to Cymbalta sales increasing for Q3. The sales of the anti-cancer drug Erbitux should also help revenues. ... Seeking Alpha (blog) Norco. Buy Tramadol Online! - Oct 31, 2009 Do not increase the effect of, Cymbalta was 24157. Do not have liver disease. Suicide is a narcotic. What other important information on the Rootsweb ... Newstalk ZB Sales, Stat! - Oct 28, 2009 Not coincidentally, 15 of the biggest recipients were psychiatrists; Lilly sells the Cymbalta antidepressant and the Zyprexa antipsychotic drugs. ... Portfolio.com Lilly CEO Lechleiter touts pipeline - Oct 23, 2009 Over the next several years, Eli Lilly will be facing generic competition for the antipsychotic Zyprexa, antidepressant Cymbalta and other blockbuster drugs ... FierceBiotech In Anxious Times, Medical Help for the Mind as Well as the Body - Nov 6, 2009 Some of the newer drugs prescribed for depression like Cymbalta, can be $100 to $200 for a 30-day supply, and your insurer will very likely charge you ... New York Times AAA: Gas-price spike slows down - Nov 8, 2009 The med that was precribved to me is Cymbalta. This was a wonder drug... Patrick Smith: Goodlatte made a comment elsewhere saying he and all 177 Republicans ... Augusta Free Press Sildenafil Ratiopharm Receives Positive Criticism From The EU Panel - Nov 12, 2009 Eli Lilly Nederland BV (developers of Cialis), with Cymbalta (duloxetine) and Boehringer Ingelheim International GmbH, with Xeristar (duloxetine), ... I-Newswire.com (press release) Purchase valium - Oct 31, 2009 How TO stop valium or Indian valium side effects of Cymbalta was nausea blurred vision? Tell your doctor for medical in, premature infants. ... Newstalk ZB Sunday Morning Quarterback | The beatdown at The U - Nov 8, 2009 The med that was precribved to me is Cymbalta. This was a wonder drug... Patrick Smith: Goodlatte made a comment elsewhere saying he and all 177 Republicans ... Augusta Free Press CORRECT: Forest Labs 2Q Net Drops 23% On Charges - Oct 20, 2009 ...s (LLY) Cymbalta depression treatment. For the period ended Sept. 30, Forest Labs' earnings fell to $186.7 million, or 61 cents a share, from $244.1 million ... Wall Street Journal Voltaren Found! - On Sale - Oct 31, 2009 Before taking Cymbalta. Physicians as soon as you are generally 1 to 2 minutes. In patients with normal daily activities in animal models. ... Newstalk ZB REG-Lilly (Eli) & Co: Lilly Rpts Solid 3Q09; Rev Full-Year 09 EPS Guidance - Oct 21, 2009 Cymbalta For the third quarter of 2009, Cymbalta generated $790.2 million in sales, an increase of 10 percent compared with the third quarter of 2008. ... Reuters Personal Health The Many Ills of Peripheral Nerve Damage - Oct 20, 2009 ...(Lyrica) and antidepressants like the tricyclic amitriptyline and the selective serotonin and norepinephrine reuptake inhibitor duloxetine (Cymbalta). ... New York Times Widespread Generic Erosion of Atypical Antipsychotics Will Cause the Bipolar ... - Nov 5, 2009 Additionally, patent expiries of branded antidepressants that include Wyeth's (now Pfizer's) Effexor XR, Eli Lilly's Cymbalta/Xeristar and Forest/Lundbeck's ... Reuters Prominent Indianapolis car dealer found dead - Nov 10, 2009 Yost previously worked as president of Brand Action Consulting and US Brand Leader for Cymbalta at Indianapolis-based Eli Lilly and Co. ... nwitimes.com Presidential Library to mark Veterans Day - Nov 9, 2009 ...need to hold them all accountable, not just one side... Chris DeWald: Thank You ladies and gentlemen. The med that was precribved to me is Cymbalta. ... Augusta Free Press buspar - HQ Pills HERE - Oct 31, 2009 If you drive or operate potentially dangerous effects, of Cymbalta was nausea. Just as, dangerous. Get tips on each trisect segment. ... Newstalk ZB PURCHASE XANAX - Oct 31, 2009 Lexapro Cymbalta alprazolam Zoloft more. In fact a licensed pharmacy. Use caution to purchase xanax avoid while taking xanax. These drugs online. ... Newstalk ZB US STOCKS-Futures lower after Boeing loss, pullback fears - Oct 21, 2009 Drugmaker Eli Lilly and Co posted better-than-expected profit, aided by higher sales of its Cymbalta anti-depressant and Alimta cancer drug, and boosted its ... Reuters South Africa BEFORE THE BELL:US Stock Futures Down But Off Lows - Oct 21, 2009 ...the antipsychotic Zyprexa, as the company saw stronger sales of both Zyprexa and depression treatment Cymbalta in latest quarter. ... Wall Street Journal Byetta gains approval as stand-alone diabetes drug - Nov 2, 2009 Lilly's key products include antipsychotic Zyprexa, Cymbalta for depression and fibromyalgia, Gemzar and Alimta for cancer, Evista and Forteo for ... Indianapolis Star Eli Lilly and Company Q3 2009 Earnings Call Transcript - Oct 21, 2009 Alimta, Cymbalta, Zyprexa, and Humalog were the principle drivers. Gemzar's international volume fell 30% compared to Q3 2008 because of generic competition ... Seeking Alpha (blog) Eli Lilly Units Pumping Up Drug Pipeline - Nov 9, 2009 Other upcoming patent expiration dates on drugs like Cymbalta, Gemzar and Evista could further impact Lilly's top-line revenues. Since biotech drugs prove ... San Diego Business Journal Forecast Insight Fibromyalgia Regulatory caution threatens EU market expansion ... - Oct 31, 2009 Since 2008, the EMEA has declined marketing applications for both Cymbalta (duloxetine, Eli Lilly/Boehringer Ingelheim) and Lyrica (pregabalin, Pfizer). ... PRMinds (press release) Bipolar drug market “to plummet from 2011â€? - Nov 10, 2009 Moreover, patent expiries of branded antidepressants that include Wyeth's - now Pfizer's - Effexor XR (venlafaxine), Eli Lilly's Cymbalta/Xeristar ... Pharma Times Merck-Schering deal wins EU nod; Pfizer moves 50 vet jobs to Kalamazoo; - Oct 23, 2009 Report > Over the next several years, Eli Lilly will be facing generic competition for the antipsychotic Zyprexa, antidepressant Cymbalta and other ... FiercePharma Lilly, Gilead impress with Q3 sales growth - Oct 21, 2009 Sales came in at $5.56 billion, on higher demand and higher prices; the antipsychotic Zyprexa, antidepressant Cymbalta, ED remedy Cialis, and cancer drug ... FiercePharma The Pulse | One reason Deeds lost - Nov 9, 2009 ...need to hold them all accountable, not just one side... Chris DeWald: Thank You ladies and gentlemen. The med that was precribved to me is Cymbalta. ... Augusta Free Press Forest Laboratories Inc. F2Q10 (Qtr End 30/09/09) Earnings Call Transcript - Oct 20, 2009 ...on the basis of fibromyalgia details remains the highest with both primary care physicians and rheumatologists, by comparison to Cymbalta or Lyrica. ... Seeking Alpha (blog) Business briefs - Oct 22, 2009 The company's second-best seller, the antidepressant Cymbalta, showed 10 percent growth, while sales for cancer drug Alimta climbed 47 percent to $462 ... News Sentinel European regulators begin Tysabri review - Oct 26, 2009 Eli Lilly's Cymbalta and Boehringer Ingelheim's Xeristar (both duloxetine) should both have their indications extended to include treatment of major ... Pharmafocus Charles River lays off 115; NeuroSearch raising $89M; - Oct 19, 2009 Report > Eli Lilly is catching heat for paying CVS Caremark to promote its Cymbalta drug to doctors. Report > Phase Forward's work to develop a faster and ... FierceBiotech Murder suspect had Rx meds - Oct 30, 2009 House — a 15-unit rooming house at 68 Broadway where Foster had been living alone — was able to identify two of the meds as Cymbalta and Trazodone. ... Taunton Daily Gazette FDA Approves Cymbalta(R) for Maintenance Treatment of Major … - Nov 30, 2007 ...(NYSE: LLY) announced today that the US Food and Drug Administration (FDA)has approved Cymbalta(R) (duloxetine HCl) for the maintenance treatment ofmajor ... Reuters - Lilly Rises On Cymbalta Gains - Apr 16, 2007 A relaunch of Eli Lilly's anti-depressant Cymbalta helped spark better than anticipated first-quarter earnings for the drug maker. ... Forbes Lilly Withdraws Cymbalta Chronic Pain Application - Nov 28, 2008 AP. Drugmaker Eli Lilly and Co. withdrew an application to have its antidepressant Cymbalta approved as a treatment for chronic pain, but the company said ... ABC News … says Lexapro depression treatment better tolerated than Cymbalta - Dec 6, 2006 In the study, Lexapro/Cipralex showed a greater reduction in depression rating scale scores and was better tolerated than Cymbalta in the treatment of ... Forbes FDA takes a hard look at Cymbalta. - Jul 2, 2005 Jul. 2--On the same day the Food and Drug Administration reiterated its warning about the potential for suicidal thinking in adults taking antidepressants, ... Free with registration - Indianapolis Star - AccessMyLibrary.com Study shows Lilly's Cymbalta cuts chronic lower-back pain - Aug 25, 2008 Eli Lilly & Co. (NYSE:LLY) announced promising data on its efforts to have its Cymbalta depression treatment also used as pain medicine, saying a study ... MarketWatch Eli Lilly says FDA OKs wider Cymbalta use - Feb 26, 2007 NEW YORK, Feb 26 (Reuters) - Eli Lilly and Co. (LLY.N) said on Monday that the US Food and Drug Administration has added treatment of generalized anxiety ... Reuters Cymbalta Receives European Approval for the Treatment of Generalised ... - Aug 22, 2008 Eli Lilly and Co (NYSE: LLY) and Boehringer Ingelheim have announced that the European Commission has approved the use of Cymbalta(R) (duloxetine) for the ... ANTARA Cypress Bioscience up on Cymbalta approval - Jun 16, 2008 NEW YORK --Shares of Cypress Bioscience Inc. surged Monday, as analysts said the Food and Drug Administration's approval of Eli Lilly & Co. ... Boston Globe FDA Broadens Liver Warning for Cymbalta - Oct 17, 2005 By Miranda Hitti. Oct. 17, 2005 -- The FDA and Eli Lilly and Co. have broadened a warning about possible liver problems with Cymbalta, a drug used to treat ... WebMD FDA says Lilly's Cymbalta promotion misleading - Oct 2, 2007 WASHINGTON (Reuters) - Eli Lilly and Co made misleading claims about its Cymbalta drug in a promotion to doctors about its use in treating nerve-related ... Reuters UK Cymbalta sales help Eli Lilly post strong quarterly earnings - Jul 22, 2006 A massive marketing campaign for its antidepressant Cymbalta along with strong growth of its newer products helped drug maker Eli Lilly and Co. earn $822 ... San Diego Union - Tribune - San Diego Union Tribune FDA Approves Cymbalta for Treatment of Fibromyalgia - Jun 17, 2008 Eli Lilly and Co. said Monday it received Food and Drug Administration approval to expand the use of its fastest-growing drug, the antidepressant Cymbalta. ... FOXNews Zyprexa, Cymbalta lead Lilly profit 6 pct higher - Oct 18, 2007 NEW YORK, Oct 18 (Reuters) - Eli Lilly and Co (LLY.N) on Thursday posted a 6 percent rise in quarterly profit on increased demand for its Cymbalta ... Reuters Eli Lilly Net Rises as Cymbalta Sales Almost Double - Oct 19, 2006 By Duncan Moore and Angela Zimm. Oct. 19 (Bloomberg) -- Eli Lilly & Co.'s third-quarter profit rose 10 percent, beating analysts' estimates by a penny, ... Bloomberg Cymbalta, Tykerb, Tysabri on US drug safety list - Sep 5, 2008 WASHINGTON, Sept 5 (Reuters) - US health officials said on Friday they are probing safety concerns with Eli Lilly and Co's (LLY.N) antidepressant Cymbalta ... Reuters UK Lilly seeks approval for Cymbalta in fibromyalgia - Aug 21, 2007 BOSTON, Aug 21 (Reuters) - Eli Lilly and Co. (LLY.N) said on Tuesday it has filed for US approval to sell its antidepressant Cymbalta as a treatment for the ... Reuters Lilly's Cymbalta Could See Market Share Gains - Dec 5, 2005 Banc of America Securities maintained a "buy" rating on Eli Lilly (nyse: LLY - news - people ) and said the company's depression drug Cymbalta should see ... Forbes Study might give Lilly, Cymbalta an edge. - May 23, 2006 May 23--Eli Lilly and Co. broadcast more good news Monday about its fast-selling antidepressant Cymbalta. The pill seems to cause less sexual dysfunction in ... Free with registration - Indianapolis Star - AccessMyLibrary.com Eli Lilly's Fourth-Quarter Profit Gains on Cymbalta - Jan 29, 2008 By Elizabeth Lopatto. Jan. 29 (Bloomberg) -- Eli Lilly & Co., the world's biggest maker of psychiatric drugs, said fourth-quarter profit gained more than ... Bloomberg Lilly's Taurel Says Cymbalta Drug Will Drive Growth - Aug 31, 2006 By Hiroshi Suzuki and Mike Firn. Sept. 1 (Bloomberg) -- Sales of Eli Lilly & Co.'s Cymbalta antidepressant climbed 92 percent in the second quarter and ... Bloomberg Lilly's Cymbalta And Forteo May Provide Upside - Sep 14, 2005 Bear Stearns maintained a "peer perform" rating on Eli Lilly (nyse: LLY - news - people ) and said investors may be under-appreciating efforts on depression ... Forbes Boehringer, Eli Lilly's anxiety drug Cymbalta approved by EU body … - Jun 27, 2008 INGELHEIM, Germany (Thomson Financial) - Boehringer Ingelheim GmbH. said the Committee for Medicinal Products in Human Use (CHMP) has recommended the ... Forbes Lilly seeks OK of Cymbalta for anxiety - May 9, 2006 INDIANAPOLIS, May 9 (UPI) -- Eli Lilly said Tuesday it has filed for approval of its anti-depressant drug Cymbalta to treat generalized anxiety disorder. ... United Press International Eli Lilly's Earnings Gain on Cialis, Cymbalta Sales - Oct 18, 2007 By Elizabeth Lopatto. Oct. 18 (Bloomberg) -- Eli Lilly & Co., the world's biggest maker of psychiatric drugs, said third-quarter profit rose 6 percent, ... Bloomberg Eli Lilly Jacks Up Guidance | Biotech/Pharmaceuticals | Financial... - Dec 9, 2005 In a separate release, Lilly announced that it will seek FDA permission next year to sell the depression treatment Cymbalta for generalized anxiety disorder ... TheStreet.com - TheStreet.com (subscription) What Are Antidepressants (Such As Prozac, Cymbalta), How Do They … - Feb 27, 2008 Question: What are antidepressants (such as Prozac, Cymbalta), how do they work, and how are they used to treat anxiety disorders? ... ABC News A Familiar Refrain at Lilly: The Pipeline - Oct 12, 2005 ..."Cymbalta is very much a third- or fourth-line option" among high-prescribing ... "Of greatest concern, Cymbalta has little traction with generalists, ... TheStreet.com - TheStreet.com (subscription) Lilly Sees Higher Earnings on Cymbalta, Byetta Sales - Dec 7, 2006 By Duncan Moore. Dec. 7 (Bloomberg) -- Eli Lilly & Co. projected a 2007 earnings increase that trailed analysts' estimates because the planned purchase of ... Bloomberg Eli Lilly's Earnings Rise on Cialis, Cymbalta Growth - Jul 24, 2008 By Elizabeth Lopatto. July 24 (Bloomberg) -- Eli Lilly & Co., the world's biggest maker of psychiatric drugs, said second-quarter earnings rose 44 percent ... Bloomberg Article: FDA takes a hard look at Cymbalta. - The Indianapolis Star (... - Jul 2, 2005 FDA takes a hard look at Cymbalta. ... find The Indianapolis Star (Indianapolis, Indiana) (viaKnight-Ridder/Tribune Business News) articles. Pay-Per-View - Indianapolis Star - HighBeam Research Eli Lilly Beats Expectations, but Acquisitions Sap Profits - Jul 25, 2007 INDIANAPOLIS, July 24 (AP) — Eli Lilly, with help from its core medicines Zyprexa and Cymbalta, beat Wall Street's second-quarter expectations Tuesday, ... New York Times Lilly Shares Discount Rebound For Zyprexa, Cymbalta - Jul 20, 2006 Prudential Equity Group maintained a "neutral weight" rating on Eli Lilly ahead of the drugmaker's second-quarter earnings report, saying shares look fairly ... Forbes FDA: Cymbalta's label, packaging changed to cut errors - Mar 18, 2008 ...s antidepressant Cymbalta has been redesigned to cut the risk of ... Cymbalta is also approved to treat diabetic nerve pain and generalized anxiety disorder ... MarketWatch Lilly Withdraws FDA Application For Cymbalta For Incontinence - Jan 28, 2005 INDIANAPOLIS, Ind. and RIDGEFIELD, Conn., Jan. 28 -- Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc. today jointly announced that Lilly ... insideindianabusiness.com Upbeat Outlook at Lilly - Dec 7, 2007 ...of several drugs that will lose their American patent protection. They include the chemotherapy agent Gemzar in 2010, Zyprexa in 2011 and Cymbalta in 2013. New York Times Lilly Posts Profit on Cymbalta; Lowers 2006 Forecast - Jul 21, 2006 By Duncan Moore. July 21 (Bloomberg) -- Eli Lilly & Co. posted a second- quarter profit as sales of its Cymbalta antidepressant almost doubled. ... Bloomberg Sales Climb at Lilly | Pharmaceuticals News | Print Financial &... - Jan 31, 2007 Cymbalta also is approved for treating nerve pain associated with diabetes. Lechleiter said he expects to hear from the FDA during the first quarter on an ... TheStreet.com - TheStreet.com (subscription) European CHMP Adopts Negative Opinion on Cymbalta for the Treatment … - Oct 27, 2008 The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a negative opinion on a Cymbalta(R) ... ANTARA New Study Suggests Cymbalta(R) Reduced Depression Symptoms At … - Dec 13, 2005 INDIANAPOLIS, Dec. 13 /PRNewswire-FirstCall/ -- Cymbalta(R) (duloxetine hydrochloride) reduced symptoms of depression at least as fast as Lexapro(R) ... Free with registration - PR Newswire - AccessMyLibrary.com Strong drug sales boost Eli Lilly profits - Apr 20, 2006 INDIANAPOLIS - Pharmaceutical maker Eli Lilly and Co. on Thursday said strong sales of its antidepressant, Cymbalta, and other newer drugs helped boost ... msnbc.com indystar.com | Printer-friendly article page - Jun 29, 2008 For Lilly, Cymbalta means new revenue without a new pill. ... Cymbalta, launched in 2004 as an antidepressant, is quickly becoming the Swiss Army knife of ... Indianapolis Star Two Drug Makers Post Gains for Quarter - Jan 27, 2006 Sales of Cymbalta more than tripled. Newer products accounted for 20 percent of total sales in the quarter and will increase to 24 percent in 2006 from 18 ... New York Times Eli Lilly says FDA approves antidepressant Cymbalta - Feb 26, 2007 ...--The online seller of wireless devices and services said excluding the impact of a settlement with the District of Columbia Attorney General and related ... Reuters Danish shares close lower, led by Vestas Wind Systems UPDATE - Dec 9, 2005 Cymbalta competes with Lundbeck's Lexapro. Chr Hansen Holding B was 10 lower at 645 after yesterday's sharp rise that followed positive broker comments and ... Forbes Eli Lilly Sues Generic-Drug Makers Over Patent for Cymbalta - Nov 17, 2008 By William McQuillen. Nov. 17 (Bloomberg) -- Eli Lilly & Co. sued four generic- drug makers, including Novartis AG's Sandoz Inc., that have been seeking to ... Bloomberg Pfizer Sees Net Income Decline 52%; The firm's third-quarter sales... - Oct 21, 2005 Lilly's Cymbalta antidepressant had a sixfold increase and its Alimta cancer drug ... Cymbalta had $182.8 million in sales and the Alimta cancer drug had ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Merrill Downgrades Lilly to Hold - Mar 28, 2006 ..."Despite the start of a new promotional campaign in January, Cymbalta NRx share has only increased 30 basis points over the past three months (from 5.8% in ... TheStreet.com - TheStreet.com (subscription) Data Suggest Cymbalta(R) Improved Functioning In Patients With … - May 22, 2007 Data suggest that patients with generalized anxiety disorder (GAD) treated with Cymbalta(R) (duloxetine HCl) experienced improved ability to perform ... Medical News Today - Medical News Today (press release) Eli Lilly 1Q profit doubles, but falls short of expectations - Apr 21, 2008 Sales for the depression treatment Cymbalta rose 37 percent to $605 million in the first quarter, driven by strong US demand and a favorable impact of ... USA Today Lilly won't reapply to expand drug's use. - Feb 16, 2006 Cymbalta is the drug that a Lilly drug-testing volunteer, 19-year-old Traci ... Concerns about a suicide risk linked to the use of Cymbalta are not the ... Free with registration - Indianapolis Star - AccessMyLibrary.com Cymbalta Reduced Anxiety Symptoms in Elderly Patients with Depression... - May 29, 2005 Cymbaltaâ„¢ (duloxetine HCL) significantly reduced anxiety symptoms in elderly patients with depression, compared with those treated with a sugar pill, ... Medical News Today - Medical News Today (press release) India pharma: Eli Lilly sues Sun Pharma over Cymbalta patent - Dec 12, 2008 US drug major Eli Lilly, continuing its fight against the generic launch of its second-largest selling drug, Cymbalta, sued Sun Pharma on December 4. ... $34.00 - EIU Country Analysis - Alacra Store Will Cymbalta Become the Second Drug Approved for Fibromyalgia? - Sep 1, 2007 Eli Lilly and Co. recently submitted a supplemental new drug application to the US Food and Drug Administration requesting that Cymbalta (duloxetine) be ... HealthCentral.com FDA lists 20 drugs under scrutiny - Sep 6, 2008 ...s antidepressant Cymbalta and AstraZeneca PLC's antipsychotic Seroquel are among 20 ... Cymbalta, for depression and other conditions, urinary retention. ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Eli Lilly 3rd-quarter profit rises 10 percent on strong Cymbalta,... - Oct 19, 2006 Eli Lilly and Co. said Thursday its third-quarter profit rose 10 percent on strong sales of the drugmaker's antidepressant Cymbalta and antipsychotic ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com European CHMP Adopts Negative Opinion on Cymbalta for the Treatment … - Oct 24, 2008 INDIANAPOLIS, Oct. 24 /PRNewswire-FirstCall/ -- The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has ... RedOrbit Discount Cymbalta COD - Apr 29, 2007 ...drug plan in the UK. [edit] Scientific Discount Cymbalta COD study of mind, brain and drugs. * Neuropharmacology - Discount Cymbalta COD Molecular and ... Sokwanele Lilly to Seek Approval For New Use For Cymbalta - Dec 9, 2005 Eli Lilly and Co. (NYSE:LLY) says it plans to submit a new drug application with the US Food and Drug Administration for Cymbalta for the treatment of ... insideindianabusiness.com Eli Lilly Withdraws Cymbalta Application - Dec 1, 2008 Eli Lilly and Company has announced that it withdrew an application to market Cymbalta as a treatment for chronic pain. Reuters is reporting that the ... Newsinferno.com Eli Lilly posts 3Q loss on Zyprexa settlement - Oct 24, 2008 Sales of the antidepressant Cymbalta climbed 40 percent to $716.4 million. ... Sales of Cymbalta and Gemzar were lifted by increased demand and higher ... USA Today Study Finds Cymbalta as Safe and Well-Tolerated as Routine Drug … - Feb 14, 2006 INDIANAPOLIS, IN -- February 14, 2006 -- A long-term study of more than 200 patients found that Cymbalta (duloxetine HCl) is as safe and well- tolerated as ... DG News FDA Approves Cymbalta® For The Management Of Fibromyalgia - Jun 20, 2008 The US Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder, ... Medical News Today - Medical News Today (press release) European approval of Cymbalta/Xeristar for treatment of major... - Jan 5, 2005 Eli Lilly and Company and Boehringer Ingelheim announced today that Cymbalta/Xeristar (duloxetine hydrochloride)(+) has been granted marketing authorization ... News-Medical.net Order Cymbalta Online - Jul 14, 2007 ...to design chemicals that act on specific cellular signalling pathways controlling cellular function). A chemical has, from the Order Cymbalta Online ... Sokwanele Lilly Submits New Application For Cymbalta - May 29, 2008 Indianapolis-based Eli Lilly and Co. (NYSE: LLY) is seeking approval from the US Food and Drug Administration to use its drug Cymbalta for the management of ... insideindianabusiness.com Lilly submits Cymbalta NDA for generalized anxiety disorder - May 10, 2006 Eli Lilly and Company has announced the recent submission of a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) for ... News-Medical.net Danish shares close lower, led down by Novo Nordisk, AP Moeller- … - Dec 6, 2006 In a new head-to-head study of Lundbeck's depression treatment, Lexapro/Cipralex, against Cymbalta, a depression treatment made by Eli Lilly and Co (nyse: ... Forbes The Surreal Life - Oct 16, 2008 Today is a Cymbalta day, which makes Barnes feel "introspective and weird." In the Athens, Georgia, band's industrial rehearsal space, downwind from a ... Rolling Stone Eli Lilly files suit against Lupin, Aurobindo - Dec 3, 2008 Cymbalta, an anti-depressant drug whose patent will expire on June, 2013, has a total global sales of around $2 billion in Eli Lilly's portfolio. ... Rediff Eli Lilly Lowers Its Revenue Forecast - Jul 22, 2006 Driving the growth was the antidepressant Cymbalta, whose revenue jumped 92 percent, to $310 million. Helped by introductions in new countries and stronger ... New York Times Patients Taking Cymbalta(R) Reported Reduced Pain Severity Of … - Jun 14, 2008 New data suggest that patients with osteoarthritis pain of the knee treated with 60 mg and 120 mg Cymbalta (duloxetine HCl) once daily experienced ... Medical News Today - Medical News Today (press release) Lilly: Study Shows Cymbalta Helps Treat Osteoarthritis Knee Pain - Jun 13, 2008 Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says new information suggests patients with osteoarthritis pain of the knee experienced significant pain ... insideindianabusiness.com No Prescription Cymbalta - Jun 21, 2007 ...* 5 Education * 6 See also * 7 Footnotes * 8 External links [edit] Medicine development and safety testing * 2 Drug legislation and safety In the United ... Sokwanele Overstated Claims Hurt: Cymbalta Ad Is Skewered - Jan 3, 2008 By Ed Silverman // January 3rd, 2008 // 9:26 am. One night while watching TV, Glen Spielmans noticed a 'Depression Hurts' ad, which is part of the marketing ... Pharmalot Cymbalta Hits a Bump in Its Road to FDA Approval - Nov 19, 2007 It has long been thought that Cymbalta (generic name duloxetine) would be the second medication to receive FDA approval for the treatment of fibromyalgia. ... HealthCentral.com EU Scientific Committee Recommends Approval of Cymbalta(R) For the … - Feb 18, 2005 INDIANAPOLIS, Indiana, February 18 /PRNewswire-FirstCall/ -- The medical advisory board of the European Medicines Agency (EMEA), which regulates ... RedOrbit Drug stocks, broader market hammered in morning trading - MarketWatch - Oct 24, 2008 Lilly also said early Friday that a European regulatory panel has recommended the EU not approve its antidepressant Cymbalta for the treatment of ... MarketWatch Eli Lilly and Co. to launch marketing campaign for diabetes drug. - Sep 19, 2007 Then there was Cymbalta and the depressed woman on the couch who couldn't face the world. Both drugs became blockbusters for Eli Lilly and Co., ... Free with registration - Indianapolis Star - AccessMyLibrary.com New study shows Eli Lilly's Cymbalta delays depression episodes. - Dec 12, 2008 New study shows Eli Lilly's Cymbalta delays depression episodes. M2 EUROPHARMA-(C)1999-2008 M2 COMMUNICATIONS LTD 12 December 2008 - New data suggest that ... $9.94 - M2 Europharma - Alacra Store … Lilly (LLY) Reports Data Suggesting Cymbalta Improved Functioning... - May 21, 2007 Eli Lilly and Company (NYSE: LLY) reports data suggests that patients with generalized anxiety disorder (GAD) treated with Cymbalta (duloxetine HCl) ... StreetInsider.com - StreetInsider.com (subscription) Study Suggests Cymbalta(R) Significantly Reduces Core Anxiety … - Mar 24, 2006 MIAMI, March 24 /PRNewswire-FirstCall/ -- A new study of approximately 500 patients evaluated the safety and efficacy of the antidepressant Cymbalta(R) ... RedOrbit Eli Lilly building on its 'robust pipeline'. - Dec 8, 2006 Sales of antidepressant Cymbalta grew 91 percent in the third quarter, compared with last year, and is on track to generate more than $1 billion in annual ... Free with registration - Indianapolis Star - AccessMyLibrary.com New antidepressant risks - Jul 20, 2006 The SNRIs, or selective serotonin/norepinephrine reuptake inhibitors, cited by the FDA are Lilly's drug Cymbalta and Wyeth's Effexor. ... TVNZ Lilly shelves new use for Cymbalta. | Article from The Indianapolis... - Jan 29, 2005 Lilly shelves new use for Cymbalta. ... find The Indianapolis Star (Indianapolis, Indiana) (viaKnight-Ridder/Tribune Business News) articles. Pay-Per-View - Indianapolis Star - HighBeam Research Free drug samples may lack life-saving information - Nov 23, 2008 He also gave her free samples of an antidepressant called Cymbalta. ... Had your daughter's doctor written her a prescription for Cymbalta, she might have ... Seattle Times Study Finds Cymbalta(R) Was As Safe And Well-Tolerated As Routine … - Feb 20, 2006 A long-term study of more than 200 patients found that Cymbalta (duloxetine HCl) is as safe and well- tolerated as current routine care that uses one or ... Medical News Today - Medical News Today (press release) Article: FDA approves Cymbalta for the management of fibromyalgia.( … - Jul 1, 2008 ...* The FDA has approved Cymbalta (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder, Eli Lilly announced recently. ... Pay-Per-View - Pharmaceutical Processing - HighBeam Research Cymbalta gets Europe go-ahead - Jan 12, 2005 A revolutionary new treatment for depression has been granted marketing authorisation by the European Commission. The new therapy is said to be able to ... DrugResearcher.com Lilly's Cymbalta shows benefit in elderly patients - Mar 8, 2005 Elderly patients with depression treated with Eli Lilly's Cymbalta had twice as much improvement in verbal learning and recalling information than those ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones [U] Land v. Dietz, No. 07-50888 (5th Cir. 04/24/2008) - Apr 24, 2008 Childers admits that he knew nothing about Cymbalta, did not contact Land's physician, and was not particularly interested in whether a drug/alcohol ... $2.95 - U.S. Court of Appeals, Fifth Circuit - VersusLaw FDA Approves Cymbalta® For Maintenance Treatment Of Major … - Dec 3, 2007 Eli Lilly and Company (NYSE: LLY) announced that the US Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the maintenance ... Medical News Today - Medical News Today (press release) Data Suggest Cymbalta(R) Reduced Severity of Night Pain in Patients … - May 3, 2007 INDIANAPOLIS, May 3 /PRNewswire-FirstCall/ -- Data from a pooled analysis of three studies suggest that in patients with pain caused by diabetic nerve ... Free with registration - PR Newswire - AccessMyLibrary.com Movers roundup: Exelixis, Cypress Bioscience - Jun 16, 2008 Food and Drug Administration's approval of Eli Lilly & Co.'s antidepressant Cymbalta as a treatment for fibromyalgia bodes well for a similar Cypress drug. Boston Globe Cymbalta approved for second indication - Mar 1, 2005 Cymbalta has received European approval for diabetic peripheral neuropathic pain (DPNP) in adults, with its marketers keen to meet what it says is unmet ... Pharmafocus Daily Migraines on Topamax, verapamil, and Cymbalta? - Jul 11, 2008 I get daily migrains. I am on !25 mgs of Topaamx, 520 mgs of Verapamil,and 60 mgs of cymbalta. I also take releplex or frova when the paim starts. ... HealthCentral.com Purchase Cymbalta Online - Jun 3, 2007 Union, the main body that regulates pharmaceuticals is the Food and Drug Administration Purchase Cymbalta Online they enforce standards set by the European ... Sokwanele Data Suggest Cymbalta® Reduced Severity Of Night Pain In Patients... - May 8, 2007 Data from a pooled analysis of three studies suggest that in patients with pain caused by diabetic nerve damage, or diabetic peripheral neuropathy, ... Medical News Today - Medical News Today (press release) Lilly's Cymbalta Shows Promising Results in Elderly Patients - Mar 7, 2005 Eli Lilly and Co. says new research shows that its anti-depressant Cymbalta is showing promising results for elderly patients. ... insideindianabusiness.com Popular prescriptions can cause drug dependence - Jun 10, 2008 ..."I had been on Zoloft and Cymbalta for about a year. I stopped the Zoloft with no problems and then was weaned off Cymbalta by gradually dropping the dosage ... Roanoke Times Brand Names/Synonyms: Cymbalta is also known by the following brand names and/or synonymsCymbalta; Domperidone; Duloxetine; Duloxetine Hcl; Duloxetine Hydrochloride; Yentreve Drug Category: Cymbalta is categorized under the following by the FDA: Antidepressants; ATC:N06AB Dosage Forms: CAPSULE Absorption: Orally administered duloxetine hydrochloride is well absorbed. Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-yl-propan-1-amine |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
